Sponsor
Pharma downplays 25% tariff impact: US healthcare could feel the blow instead of India- what sector experts say
Posted
India’s pharma sector has downplayed the impact of US President Trump’s 25% tariff, warning instead of severe consequences for American healthcare. Industry leaders stressed India’s key role in supplying affordable medicines to the US and predicted shortages, higher costs, and a 3–5 year struggle for the US to find alternatives.
Zoeken
Categorieën
- National
- International
- Business
- Technology
- Health
- Onderwijs
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
All about Rajinikanth's speech at the 'Coolie' audio launch
Rajinikanth's 'Coolie' audio launch was a grand affair, filled with nostalgic moments and...
Osbourne's daughter pays tribute days after funeral
Ozzy Osbourne, the iconic 'Prince of Darkness,' died at 76 after battling Parkinson's. His...
Official! Pakistan impose blanket ban on future WCL participation - details inside
The Pakistan Cricket Board (PCB) has officially banned participation in future World Championship...
IND vs ENG: Washington and Prasidh creates a unique history - Details inside
Washington Sundar and Prasidh Krishna's unbeaten 39-run partnership set a record for India, with...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Dutch
